Bard PowerPort Device Linked to Fracture, Migration, and Thrombosis
The Bard PowerPort catheter is an implanted port device placed under the skin and connected to a central vein to provide repeated access to the bloodstream. In these cases, the Bard PowerPort implanted device remains in the body for extended periods during treatment.
The Bard PowerPort has inherent design and manufacturing flaws that make the device prone to fracturing and migrating out of position, reflecting broader problems with Bard Power Port devices.
The primary material used in the Bard PowerPort catheter is Chronoflex AL, which has been reported to contain significant design flaws.
Barium sulfate is used in the Bard PowerPort catheter to enhance visibility in medical imaging, but it allegedly compromises the catheter’s structural integrity.
The inclusion of barium sulfate in the catheter material produces microfractures within the Chronoflex AL material, making it vulnerable to cracking.
As the material weakens, the catheter may develop surface damage, lose stability, or fracture within the vein, affecting how blood flows around the device.
As the catheter weakens or fractures inside the vein, specific mechanical changes can occur that increase the risk of clot formation, including:
- Rough or damaged catheter surfaces that disturb normal blood flow
- Movement of the catheter that can irritate vessel walls
- Fracture that may lead to partial obstruction inside the vein
Thrombosis, or blood clots, can form around the Bard PowerPort due to its design flaws, disrupting normal blood flow and posing life-threatening risks.
If you or a loved one has suffered from thrombosis or blood clots linked to a Bard PowerPort device, you may be eligible to file a Bard PowerPort lawsuit.
Contact TorHoerman Law for a free case evaluation, or use the chatbot on this page to find out if you qualify to file a Bard PowerPort lawsuit.
What Is the Bard PowerPort Device?
The Bard PowerPort catheter device is an implanted port catheter device used to provide repeated access to a patient’s bloodstream during long-term treatment.
It is commonly placed under the skin and connected to a central vein, allowing physicians to deliver medications or draw blood without repeated needle insertion.
The Bard implanted port catheter is typically used in patients requiring ongoing intravenous therapy, including chemotherapy, antibiotics, or other long-term treatments.
The device remains in place for extended periods and is accessed through the skin using a needle.
Implantation involves a minor surgical procedure in which the port is positioned beneath the skin and the catheter is guided into a major vein.
Once placed, the device functions as a stable access point for infusion systems and medical procedures.
Over time, the performance of the Bard port catheter depends on its structural integrity and positioning within the vein, which are central issues raised in ongoing Bard PowerPort cases.
What are Port Catheters Used For?
A port catheter device is used when treatment requires regular access to a central vein over a long period. This type of implanted port catheter device is placed under the skin and remains in the body to support ongoing care without repeated IV placement.
Use of a bard port catheter is common in conditions where patients need continuous or repeated intravenous access, especially when treatment extends over weeks or months.
The catheter stays inside a major vein, which makes it different from temporary IV lines and changes how blood flows around it.
Port catheter devices are often used for:
- Chemotherapy and high-risk medications: Strong drugs are given through central veins to avoid damage to smaller veins and to allow steady entry into the bloodstream during each treatment session.
- Long-term IV therapy and treatment cycles: Patients receiving antibiotics, fluids, or nutrition support rely on the same access point over time, reducing the need for repeated needle insertion.
- Repeated blood testing and monitoring: The device allows blood samples to be taken multiple times during treatment, which is important for tracking response and adjusting care.
- Continuous presence inside the vein: The catheter remains in contact with circulating blood between treatments, which can affect blood movement and may become relevant in cases involving clot formation or thrombosis.
Long-term use is important context in Bard PowerPort cases, where device condition, placement, and interaction with blood flow are examined in relation to medical complications and reported injuries.
Bard PowerPort Complications: What is Wrong with Bard PowerPort Devices?
Plaintiffs allege that Bard failed to adequately warn patients and healthcare providers about the risks associated with the PowerPort device.
Bard PowerPort lawsuits allege that the manufacturer failed to adequately warn patients and healthcare providers about the risks associated with the device.
Lawsuits also claim that the device’s design and material composition render it particularly brittle, leading to fractures.
The design flaws in the Bard PowerPort have been linked to severe complications, including infections, blood clots, and internal injuries.
Many patients have filed lawsuits after experiencing complications linked to a defective Bard PowerPort device.
Many of these complications begin with catheter failure.
Catheter migration happens when the implant or a fragment breaks and moves through the bloodstream.
As the catheter or its fragments move through blood vessels, they may reach narrow areas and interfere with normal blood flow.
As the catheter or its fragments move through blood vessels, they may reach narrow areas and interfere with normal blood flow.
With the blood flow obstructed, blood clots can develop and cause further blockage, leading to several serious complications.
How is Thrombosis Treated?
Once thrombosis develops, treatment focuses on stopping clot growth and restoring blood flow.
Common treatments for thrombosis include anticoagulation therapy, thrombolytic therapy, catheter removal, and advanced procedures such as mechanical thrombectomy.
Treatment may involve the following approaches:
- Anticoagulation therapy: Medications such as heparin, warfarin, or direct oral anticoagulants (DOACs) are used to prevent clot growth and new clot formation.
- Thrombolytic therapy: Thrombolytic therapy may involve instilling a low dose of a thrombolytic agent such as alteplase directly into the port to dissolve the blockage.
Routine port maintenance also plays a role in reducing complications.
Routine port maintenance includes regular flushing with saline and possibly heparin every 4 weeks when not in use to maintain patency.
Proactive care practices such as proper port flushing, maintaining mobility, and hydration can reduce the risk of device-related thrombosis.
What Is Deep Vein Thrombosis (DVT)?
Deep vein thrombosis (DVT) is a condition where a blood clot forms within a deep vein, most commonly in the lower extremities or in central veins used for long-term vascular access.
In Bard PowerPort cases, thrombosis is evaluated in the context of an implanted port catheter device placed directly into a major vein.
The presence of a foreign device inside the bloodstream can alter normal blood flow and affect how blood moves around the catheter surface.
Plaintiffs allege that in certain Bard PowerPort devices, structural issues such as catheter damage, surface irregularities, or migration may contribute to clot formation.
These conditions can disrupt circulation and create an environment where blood clots develop around or within the catheter.
If a clot progresses or detaches, it may travel through the bloodstream and lead to a pulmonary embolism, a condition involving blockage of blood flow in the lungs.
Seek immediate medical attention if symptoms of a blood clot or port failure are suspected to prevent serious complications.
How DVT or Pulmonary Embolism Occurs After a Catheter Migration
DVT occurs when a blood clot forms in a deep vein.
In Bard PowerPort cases, this may develop around a catheter placed inside a central vein for long-term vascular access.
When the catheter remains stable, blood can flow around it with limited disruption.
Plaintiffs allege that if the catheter migrates, shifts, or becomes misaligned, it may contact and irritate the vessel wall.
This irritation can trigger the body’s clotting response.
Clots may then form at or near the catheter site, particularly where blood flow becomes uneven or restricted.
Surface damage or structural issues may further disturb circulation.
Signs and Symptoms of Deep Vein Thrombosis (DVT)
Early identification of DVT is important because clot progression can lead to more serious complications.
Common signs and symptoms of DVT may involve changes in the affected limb, especially where blood flow is restricted.
These may include:
- Swelling in the legs or near the catheter site
- Pain or tenderness, often worsening with movement
- Redness or warmth over the affected area
These symptoms may develop around the vein where the catheter is positioned, particularly if blood flow becomes disrupted.
More severe symptoms can occur if the clot travels through the bloodstream. Sudden shortness of breath, chest pain, or difficulty breathing may indicate a pulmonary embolism.
These signs require immediate medical evaluation, as they suggest that a clot has moved beyond the original site and is affecting circulation in the lungs.
Complications of DVT
Thrombosis can lead to complications such as deep vein thrombosis (DVT) and pulmonary embolism.
Complications arising from DVT can be severe and are often linked to how the clot affects blood flow or moves within the vascular system.
If a clot dislodges and travels to vital organs such as the lungs, it can result in a pulmonary embolism.
This can impair oxygen exchange and place strain on the heart, particularly when blood flow through the lungs becomes restricted.
In some cases, DVT may also lead to chronic conditions such as post-thrombotic syndrome, where persistent pain, swelling, and skin changes develop due to long-term vein damage.
Complications of deep vein thrombosis (DVT) include:
- Pulmonary Embolism (PE): A potentially life-threatening condition where a blood clot breaks away from the DVT site, travels to the lungs, and blocks blood flow, affecting oxygen exchange.
- Post-Thrombotic Syndrome: A long-term medical condition following DVT, involving persistent pain, swelling, and skin discoloration due to damage to the affected vein.
- Phlegmasia Cerulea Dolens: A severe form of DVT causing extensive swelling and bluish discoloration of the limb due to near-complete venous obstruction.
- Phlegmasia Alba Dolens: A severe DVT-related condition marked by limb swelling and pallor caused by reduced venous outflow and compromised circulation.
- Venous Gangrene: Tissue death resulting from prolonged and severe venous obstruction, which may require surgical intervention, including amputation.
- Chronic Venous Insufficiency: A condition where damaged veins cannot effectively return blood to the heart, leading to ongoing swelling, skin changes, and ulcer formation.
- Superficial Vein Thrombosis: Extension of clot formation into superficial veins, which may progress or coexist with deeper venous clotting.
- Recurrent DVT: The formation of new clots after a prior DVT, increasing the risk of additional vascular complications.
- Compartment Syndrome: Increased pressure within a limb due to swelling, which can restrict blood flow and damage muscles and nerves if not treated.
Bard PowerPort Lawsuit Overview
Bard PowerPort lawsuits are part of a broader port catheter lawsuit involving allegations that implantable port devices caused serious complications after placement.
These claims have been consolidated in the Bard PowerPort MDL in the United States District Court for the District of Arizona.
The litigation was centralized by the United States Judicial Panel on Multidistrict Litigation, often referred to as the judicial panel, to coordinate similar claims filed across the country.
The MDL is overseen by Judge David G. Campbell, sometimes referenced as Judge Campbell, who manages pretrial proceedings in the district court.
Plaintiffs have filed pending lawsuits against Bard and its parent company, Becton Dickinson and Company, alleging injuries linked to these defective medical devices.
The Bard PowerPort MDL grew as additional claims were filed, reflecting increasing scrutiny of device performance and reported complications.
Pretrial proceedings include the discovery process, a case management conference, and periodic status conference hearings to organize the litigation.
Bard PowerPort lawsuit allegations include:
- Catheter fracture, material breakdown, or structural weakness after implantation
- Device migration or embolization within the vascular system
- Increased risk of thrombosis, infection, or other vascular complications
- Failure to adequately warn patients and physicians about known risks
- Design and manufacturing defects affecting long-term durability
- Injuries supported in part by adverse event reports documenting real-world complications
As the litigation progresses, the court is preparing bellwether cases to evaluate how juries may respond to the evidence.
A Bard PowerPort trial in one of these early cases may influence how similar claims are assessed moving forward.
The outcome of these proceedings may shape settlement discussions across the MDL.
Each claim remains fact-specific and depends on the medical evidence, device history, and the alleged connection between the device and the reported injury.
Estimated Bard PowerPort Lawsuit Settlements
The Bard PowerPort litigation has not reached a global settlement stage.
The potential settlement value of individual Bard PowerPort claims will depend on various factors and circumstances, particularly the type of occurrence or event the plaintiff experienced and the resulting injuries.
Settlement value in these cases is tied to how serious the injury is, what treatment was required, and whether the condition caused lasting harm.
Courts and parties usually look at a combination of factors when assessing value, including:
- The type of injury, including thrombosis or pulmonary embolism
- Whether hospitalization or emergency surgery was required
- The length and cost of treatment
- Whether the injury caused long-term impairment
For clot-related claims, the focus is on how the thrombosis affected blood flow and whether it led to further complications.
Cases of thrombosis or pulmonary embolism may have a settlement value of around $100,000 to $250,000.
Where the injury involves more serious vascular damage, the projected value may be higher due to the extent of harm and treatment involved.
Cases involving vascular damage directly resulting from at least one occurrence event could have a settlement payout value ranging from $175,000 to $350,000.
Claims involving infection are generally assessed differently, especially where the condition resolves without permanent damage.
Infection cases related to Bard PowerPort devices is estimated have a settlement value range of $30,000 to $100,000.
Some projections attempt to estimate a broader range across all claims, but these should not be treated as guarantees.
The average settlement payout for the PowerPort lawsuits is projected to be between $150,000 to $300,000, with some claims exceeding $1 million.
These figures may change as the litigation moves forward and more evidence is presented.
Each claim is evaluated on its own facts, and any final result depends on the medical record, the treatment history, and the strength of the connection between the Bard PowerPort device and the reported injury.
Do You Qualify for a Bard PowerPort Lawsuit?
Eligibility for the Bard PowerPort lawsuit is determined by whether the available facts and medical evidence support a product liability claim involving the implanted device.
These cases arise within ongoing litigation concerning alleged defects in Bard PowerPort and related port catheter systems.
A viable claim is generally supported by a combination of specific elements that must be established through objective documentation:
- Documented implantation of a Bard PowerPort device
- A medically diagnosed condition arising after implantation
- Medical evidence supporting a causal relationship between the device and the injury
Each element is evaluated together rather than in isolation.
Surgical and hospital records are used to confirm device implantation, while diagnostic reports and treatment records establish the nature of the condition and the course of medical care that followed.
The timing of the injury in relation to implantation is also relevant.
Medical records are reviewed to determine when symptoms first appeared, how they progressed, and what interventions were required, including hospitalization or surgical procedures.
This timeline is often central to evaluating whether the injury may be linked to the device.
Many claims involve individuals who relied on the device for extended treatment, including cancer patients requiring repeated vascular access.
Their treatment history can provide a continuous medical record that helps assess both injury development and causation.
A Bard PowerPort claim is assessed based on whether the evidence supports a consistent link between the device, the diagnosed condition, and the resulting treatment.
Where these elements are supported, an individual may have grounds to pursue a Bard PowerPort lawsuit.
If your circumstances align with these factors, contact TorHoerman Law for a case evaluation or use the chatbot on this page to determine whether your situation fits within current Bard PowerPort claims.
Gathering Evidence for the Bard PowerPort Lawsuit
A Bard PowerPort thrombosis claim relies on records showing the device was implanted, a clot-related condition developed, and the condition can be medically linked to the catheter.
The analysis focuses on how the device functioned inside the vein, including whether its position, condition, or structural changes contributed to disrupted blood flow and clot formation.
These claims are supported by specific categories of medical and financial records:
- Operative and implant records confirming Bard PowerPort placement
- Device identification details from surgical or hospital records
- Imaging studies showing thrombosis or venous obstruction
- Radiology reports evaluating catheter position or migration
- Clinical records documenting symptoms, diagnosis, and progression of the condition
- Treatment records showing anticoagulation, thrombolysis, or catheter removal
- Medical timeline linking symptom onset to device implantation
- Physician opinions addressing whether the catheter contributed to clot formation
- Billing and employment records showing financial loss
These records are reviewed together to evaluate whether the thrombosis developed in a way that can be linked to the Bard PowerPort device.
That evaluation centers on timing, clinical findings, and whether the catheter’s presence or condition aligns with the development of the clot.
Assessing Damages in Bard PowerPort Lawsuits
Damages in Bard PowerPort lawsuits depend on the type of complication, the treatment required, and whether the injury caused lasting harm.
Claims involving thrombosis, catheter fracture, or migration are evaluated based on how the condition affected blood flow, required intervention, or led to complications such as pulmonary embolism.
Damages may include:
- Past medical bills for diagnosis, hospitalization, and treatment
- Future medical expenses, including ongoing care and medication
- Costs of procedures such as catheter removal or surgical intervention
- Lost wages during treatment and recovery
- Loss of earning capacity
- Pain and suffering
- Permanent impairment or long-term complications
Cases involving emergency surgery, pulmonary embolism, or lasting vascular damage are generally evaluated at a higher level than cases that resolve without ongoing effects.
TorHoerman Law: Contact a Bard PowerPort Attorney Today
Our team of dedicated attorneys, with more than 100 years of combined litigation experience, have helped clients win more than $4 billion in verdicts and negotiated settlements for injuries suffered at no fault of their own.
If you or a loved one were injured by Bard PowerPort devices, you may be eligible to file a Bard PowerPort lawsuit against the medical device manufacturer.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for a Bard PowerPort Lawsuit instantly.
Our attorneys work on a contingency fee basis – so our clients don’t pay any legal fees unless they are awarded compensation for their injuries & other losses.
Reach out to us if you were injured by a defective device. We’re here to help you.
